- Home
- ZJYL vs GNLX Comparison
ZJYL vs GNLX Comparison
Compare ZJYL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- GNLX
- Stock Information
- Founded
- ZJYL 2006
- GNLX 2001
- Country
- ZJYL China
- GNLX United States
- Employees
- ZJYL N/A
- GNLX N/A
- Industry
- ZJYL Industrial Specialties
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- ZJYL Consumer Discretionary
- GNLX Health Care
- Exchange
- ZJYL Nasdaq
- GNLX Nasdaq
- Market Cap
- ZJYL 111.3M
- GNLX 128.0M
- IPO Year
- ZJYL 2023
- GNLX 2023
- Fundamental
- Price
- ZJYL $0.63
- GNLX $3.95
- Analyst Decision
- ZJYL
- GNLX Strong Buy
- Analyst Count
- ZJYL 0
- GNLX 4
- Target Price
- ZJYL N/A
- GNLX $17.75
- AVG Volume (30 Days)
- ZJYL 338.2K
- GNLX 134.7K
- Earning Date
- ZJYL 08-20-2025
- GNLX 11-13-2025
- Dividend Yield
- ZJYL N/A
- GNLX N/A
- EPS Growth
- ZJYL N/A
- GNLX N/A
- EPS
- ZJYL 0.01
- GNLX N/A
- Revenue
- ZJYL $22,826,624.00
- GNLX N/A
- Revenue This Year
- ZJYL N/A
- GNLX N/A
- Revenue Next Year
- ZJYL N/A
- GNLX N/A
- P/E Ratio
- ZJYL $55.25
- GNLX N/A
- Revenue Growth
- ZJYL 13.42
- GNLX N/A
- 52 Week Low
- ZJYL $0.50
- GNLX $1.95
- 52 Week High
- ZJYL $4.08
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- ZJYL 45.17
- GNLX 63.93
- Support Level
- ZJYL $0.57
- GNLX $3.56
- Resistance Level
- ZJYL $0.72
- GNLX $3.61
- Average True Range (ATR)
- ZJYL 0.07
- GNLX 0.24
- MACD
- ZJYL -0.01
- GNLX 0.03
- Stochastic Oscillator
- ZJYL 19.93
- GNLX 84.42
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.